This manual provides basic information on TB testing, and lists key points in evaluating, treating, and monitoring children and adolescents who have latent TB infection.
This report presents information about the Global TB Drug Facility, a program designed to ensure access to and the availability of TB drugs.
This manual presents guidelines for employers to implement TB control activities in the workplace.
This report discusses the economic, psychological, and social impacts of TB and the strategies that households use to cope with them.
This report presents a tools package for public-private mix initiatives for DOTS implementation (PPM-DOTS) as a means of TB control. The purpose is to help national TB program (NTP) managers begin involving private providers (PPs) in DOTS implementation and to sustain collaboration.
This report assesses the effectiveness, cost, and cost-effectiveness of the public-private mix DOTS (PPM-DOTS) program in pilot projects in Hyderabad and Delhi, India.
This guide provides information about TB treatment for TB supporters who ensure that patients take their TB drugs regularly and on schedule for the full duration of the treatment.
This prospectus is a culmination of input from Stop TB Partners including representatives from TB high-burden countries, UN agencies, Nongovernmental Organizations (NGOs), and foundations to develop the form, strategies, objectives, and governance of the Global TB Drug Facility (GDF).
This guide provides information about TB treatment for TB supporters who ensure that patients take their TB drugs regularly, on schedule, for the full duration of the treatment.
This fact sheet explains the purpose of the Global Drug Facility (GDF) to expand access to, and availability of, high-quality TB drugs to facilitate DOTS expansion, and to enable governments and nongovernmental organizations (NGOs) to implement effective TB control programs based upon the DOTS stragegy.
